How to become a science entrepreneur – Chemistry World interviews Dr Simon Hirst

8th July 2017 – With fierce competition and a scarcity of posts beyond post-doctoral level, many chemists see starting their own business as an alternative career path. But even for those researchers coming from an industry background, venturing into business can seem daunting. Chemistry World recently spoke to some entrepreneurial insiders, including Dr Simon Hirst, […]

Sir John Peace, Midlands Engine Chairman, opens Discovery Building, Sygnature’s New HQ

28th June 2017 – Nottingham, UK – Sir John Peace has officially opened Sygnature Discovery’s new HQ, the purpose-built Discovery Building located at BioCity Nottingham.  The £30 million building contains 50,000 sq ft of chemistry and biology laboratory and office space on five levels.  Sygnature Discovery is currently occupying three levels of the building. Addressing […]

Unlocking efficiency in drug discovery: GE Healthcare’s The Pulse visits Sygnature Discovery

15th June 2017 – The Pulse recently interviewed Dr Scott Pollack, Associate Director, Biophysics and Enzymology, and Dr Paul Clewlow, Senior VP, Business Development, about how Sygnature Discovery is accelerating their ambitious clients’ drug discovery programs and helping them to increase their productivity through the application of cutting-edge technology, such as the Biacore 8K surface […]

Sygnature Discovery’s CEO Dr Simon Hirst talks to Chemistry World about growth

  14th June 2017 – What a difference a year makes!  Chemistry World caught up with Dr Simon Hirst, Sygnature Discovery’s Founder and CEO, one year after he was named as the Royal Society of Chemistry’s ‘Chemistry World Entrepreneur of the Year’ 2016. Since then the company has risen to even great heights and now […]

SelectScience Editorial Article: Insights into the UK’s Largest Independent Integrated Drug Discovery CRO

1st June 2017 – SelectScience recently interviewed Denise Swift, a Senior Bioscientist, Project and Team Leader at Sygnature Discovery.  Denise is responsible for evaluating new technologies to enhance Sygnature’s Bioscience capabilities – in particular, screening technologies, instrumentation and automation. The interview highlighted Sygnature Discovery’s novel approach to custom assay development and revealed some of the […]

Page 4 of 15« First...23456...10...Last »
Copyright © 2018 Sygnature Discovery

Website built by AtomicMedia - Design by Freestyle.